AVADEL PHARMACEUTICALS PLC Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Avadel Pharmaceuticals Plc quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Avadel Pharmaceuticals Plc Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $21.4M, a 322% increase year-over-year.
  • Avadel Pharmaceuticals Plc annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$50.1M, a 163% decline from 2022.
  • Avadel Pharmaceuticals Plc annual Net Cash Provided by (Used in) Investing Activities for 2022 was $79.7M, a 40% increase from 2021.
  • Avadel Pharmaceuticals Plc annual Net Cash Provided by (Used in) Investing Activities for 2021 was $56.9M.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $21.4M +$16.3M +322% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $5.07M -$37.2M -88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $42.3M +$31.1M +278% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $11.2M -$2.04M -15.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $13.2M -$8.16M -38.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $21.4M +$102M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 -$80.7M -$48.8M -152% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 -$32M +$9M +22% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q1 2016 -$41M -$17.6M -74.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 -$23.4M +$4.36M +15.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 -$27.8M -$32.4M -705% Jan 1, 2014 Mar 31, 2014 6-K 2014-07-08
Q1 2013 $4.6M -$44K -0.95% Jan 1, 2013 Mar 31, 2013 6-K 2014-07-08
Q1 2012 $4.64M +$1.24M +36.3% Jan 1, 2012 Mar 31, 2012 6-K 2012-09-13
Q1 2011 $3.41M Jan 1, 2011 Mar 31, 2011 6-K 2012-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.